Summary
Familial hypercholesterolemia (FH), at a prevalence of about 1 in 200 in the French-Canadian population, is caused by a 10-kb deletion in the low-density lipoprotein (LDL) receptor gene in 60% of French-Canadian FH heterozygotes. We genotyped 159 FH patients who carry this common mutation and 221 healthy French-Canadian controls for five DNA restriction fragment length polymorphisms (RFLPs) of the LDL receptor gene. The allele numbers for four of the five RFLPs differed significantly (P < 0.001) between FH patients and control subjects. Our results suggest that the 10-kb deletion carrier allele is associated with a single haplotype (called the B haplotype). In a family study including a patient homozygous for the 10-kb deletion, we showed that the B haplotype cosegregates with the deletion in affected members and that the B haplotype is also associated with the normal allele in some members of the family. We identified 15 different haplotypes for the normal allele in 10-kb deletion carrier FH heterozygotes. These results offer strong support, at a molecular level, for the hypothesis of a founder effect for the 10-kb deletion in the French-Canadian population.
Similar content being viewed by others
References
Aalto-Setala K, Gylling H, Miettinen T, Kontula K (1988) Identification of a deletion in the LDL receptor gene: a Finnish type of mutation. FEBS Lett 230:31–34
Allain CB, Poon LS, Chan FCS, Richmond F, Fu PC (1974) Enzymatic determination of total serum cholesterol. Clin Chem 20:470–475
Andersen GE, Lous P, Fiis-Hansen B (1979) Screening for hyperlipoproteinemia in 10,000 Danish newborns: follow-up studies in 522 children with elevated cord serum VLDL-LDL cholesterol. Acta Pediatr Scand 68:541–545
Baird PA (1990) Genetics and health care: a paradigm shift. Perspect Biol Med 33:203–213
Bouchard G, Braekeleer M de (1990) Homogénéité ou diversité? L'histoire de la population du Québec revue à travers les gènes. Hist Soc 23:325–361
Brink PA, Steyn IT, Coetzee GA, Van der Westhuyzen DR (1987) Familial hypercholesterolemia in South African Afrikaners: PvuII and StuI DNA polymorphisms in the LDL receptor gene consistent with a predominating founder effect. Hum Genet 77:32–35
Charbonneau H, Desjardins B, Guillemette A, Landry Y, Legaré J, Nault F (1987) Naissance d'une population: les Francais établis au Canada au XVIIe siècle. INED/PUM, Paris Montréal, pp 1–232
Daga A, Fabbi M, Mattioni T, Bertolini S, Corte G (1988) PvuII polymorphism of low density lipoprotein receptor gene and familial hypercholesterolemia. Arteriosclerosis 8:845–850
Davignon J, Roy M, Dufour R, Roederer G (1991) Familial hypercholesterolemia In: Steiner G, Shafrir E (eds) The hyperlipidemias, vol 1: Primary hyperlipidemias. McGraw Hill Book, New York, pp 201–234
Feinberg AP, Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6–13
Gevers W, Casciola LAF, Fourie AM, Sanan DA, Coetzee GA, Van der Westhuyzen DR (1987) Defective LDL receptors that are common in a large population: familial hypercholesterolemia in South Africa. Biol Chem 368:1233–1243
Goldstein JL, Brown MS (1983) Familial hypercholesterolemia. In: Stanbury JB, Wyngaarden JB, Fredrickson DS, Goldstein JL (eds) The metabolic basis of inherited diseases, 5th edn. New York, McGraw Hill, pp 672–712
Heiberg A, Berg K (1976) The inheritance of hyperlipoproteinaemia with xanthomatosis: a study of 132 kindreds. Clin Genet 9:203–233
Hobbs HH, Brown MS, Russell DW, Davignon J, Goldstein JL (1987) Deletion in the gene for low-density-lipoprotein receptor in a majority of French-Canadians with familial hypercholesterolemia. N Engl J Med 317:734–737
Hobbs HH, Leitersdorf E, Goldstein JL, Brown MS, Russell DW (1988) Multiple crm-mutations in familial hypercholesterolemia: evidence for 13 alleles, including four deletions. J Clin Invest 81:909–917
Hobbs HH, Russell DW, Brown MS, Goldstein JL (1990) The LDL receptor locus in familial hypercholesterolemia: mutational analysis of membrane protein. Annu Rev Genet 24:133–170
Humphries SE, Kessling AM, Horsthemke B, Donald JA, Seed M, Jowett N, Holm M, Galton DJ, Wynn V, Williamson R (1985) A common DNA polymorphism of the low-density lipoprotein (LDL) receptor gene and its use in diagnosis. Lancet 1:1003–1005
Jomphe M, Bouchard G, Davignon J, De Braekeleer M, Gradie M, Kessling AM, Laberge C, Moorjani S, Morgan K, Roy M, Scriver C (1988) Familial hypercholesterolemia in French-Canadians: geographical distribution and centre of origin of an LDL-receptor deletion mutation. American Society of Human Genetics, New Orleans, Louisiana (abstract)
Kessling AM, Ouellette S, Bouffard O, Chamberland A, Bétard C, Selinger E, Xhignesse M, Lussier-Cacan S, Davignon J (1991) Patterns of association between genetic variability in apolipoprotein (apo) B, apo AI-CIII-AIV and cholesterol ester transfer protein gene regions and quantiative variation in lipid and lipoprotein traits are influenced by gender and exogeneous hormones. Am J Hum Genet (in press)
Khachadurian AK, Uthman SM (1973) Experiences with the homozygous cases of familial hypercholesterolemia. Nutr Metabol 15:132–140
Kotze MJ, Retief AE, Brink PA, Weich HFH (1986) A DNA polymorphism in the human low-density lipoprotein receptor gene. S Afr Med J 70:77–79
Kotze MJ, Langenhoven E, Dietzsch E, Retief AE (1987a) A RFLP associated with the low-density lipoprolein receptor (LDLR) Nucleic Acids Res 15:376
Kotze MJ, Langenhoven E, Retief AE, Steyn K, Marais MP, Grobbelaar JJ, Oosthuizen CJJ, Weich HFH, Benade AJS (1987b) Haplolype associations of three DNA poylmorphisms at the human low density lipoprotein receptor gene locus in familial hypercholesterolemia. J Med Genet 24:750–755
Kotze MJ, Langenhoven E, Retief AE, Seftel HC, Henderson HE, Weich HFH (1989) Haplotypes identified by 10 DNA restriction fragment length polymorphisms at the human low densily lipoprotein receptor gene locus. J Med Genet 26:255–259
Kunkel LM, Smith KD, Boyer SH, Borgaonkar DS, Wachtel SS, Miller OJ, Breg WR, Jones HW Jr, Rary JM (1977) Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants. Proc Natl Acad Sci USA 74:1245–1249
Laberge C (1966) Prospectus for genetic studies in the French Canadians, with preliminary data on blood groups and consanguinity. Bull Johns Hopkins Hosp 118:52–68
Lehrman MA, Schneider WJ, Brown MS, Davis CG, Elhammer A, Russell DW, Goldstein JL (1987) The Lebanese allele at the low density lipoprotein receptor locus: nonsense mutation produces truncated receptor that is retained in endoplasmic reliculum. J Clin Chem 262:401–410
Leitersdorf E, Hobbs HH (1987) Human LDL receptor gene: two ApaLI RFLPs. Nucleic Acids Res 15:2782
Leitersdorf E, Chakravarti A, Hobbs HH (1989) Polymorphic DNA haplotypes at the LDL receptor locus. Am J Hum Genet 44:409–421
Leitersdorf E, Tobin EJ, Davignon J, Hobbs HH (1990) Common low-density lipoprotein receptor mutations in the French Canadian population. J Clin Invest 85:1014–1023
Lipid Research Clinics Program (1974) Manual of Laboratory Operations, vol 1: Lipid and lipoprotein analysis. (DHEW publication no (NIH) 75–628,) US Government Printing Office 1–81, Washington, DC
Lussier-Cacan S, Bouthillier D, Davignon J (1985) Apo E allele frequency in primary endogenous hypertriglyceridemia. Arteriosclerosis 5:639–643
Ma Y, Bétard C, Roy M, Davignon J, Kessling AM (1989) Identification of a second “French Canadian” LDL receptor gene deletion and development of a rapid method to detect both deletions. Clin Genet 36:219–228
Manialis T, Frisch EF, Sambrook J (1982) Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
Moorjani S, Roy M, Gagné C, Davignon J, Brun D, Toussaint M, Lambert M, Campeau L, Blaichman S, Lupien P (1989) Homozygous familial hypercholesterolemia among French-Canadians in the Province of Quebec. Arteriosclerosis 9:211–216
Pedersen JC, Berg K (1988) Normal DNA polymorphism at the low density lipoprolein (LDLR) locus associated wilh serum cholesterol level. Clin Genet 34:306–312
Reardon MF, Poapst ME, Uffelman KD, Steiner G (1981) Improved method for quantification of B apoprotein in plasma lipoproteins by electro-immunoassay. Clin Chem 27:892–895
Rosseneu M, Vinaimont N, Vercaemst R, Dekeersgieter W, Belpaire F (1981) Standardization of immunoassays for the quantitation of plasma Apo B protein. Anal Biochem 116:204–210
Sampson EJ, Demers LM, Krieg AF (1974) Faster enzymatic procedure for serum triglycerides. Clin Chem 21:1983–1985
Seftel HC, Baker SG, Sandler MP, Forman MB, Joffe BI, Mendelson D, Jenkins T, Mieny CJ (1980) A host of hypercholesterolaemic homozygotes in South Africa. Br Med J 281:633–636
Schuster H, Stiefenhofer B, Wolfram G, Keller C, Humphries S, Huber A, Zollner N (1989) Four DNA polymorphisms in the LDL receptor gene and their use in diagnosis of familial hypercholesterolemia. Hum Genet 82:69–72
Sing CF, Moll PP (1990) Genetics of atherosclerosis. Annu Rev Genet 24:171–189
Slack J (1979) Inheritance of familial hypercholesterolemia. Atheroscler Rev 5:35–66
Taylor R, Jeenah M, Seed M, Humphries SE (1988) Four DNA polymorphisms in the LDL receptor gene: genetic relationship and use in the study of variation at the LDL receptor locus. J Med Genet 25:653–659
Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J (1991) Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health. Arteriosclerosis 11:1100–1110
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bétard, C., Kessling, A.M., Roy, M. et al. Molecular genetic evidence for a founder effect in familial hypercholesterolemia among French Canadians. Hum Genet 88, 529–536 (1992). https://doi.org/10.1007/BF00219339
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00219339